This is to infor you that the 32nd Annual General Meeting(AGM) of the Company will be held on Monday, 29th September, 2025 and E oting period for AGM commences on Friday, 26/09/2025 (09:00 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Drugs & Industries has called its 32nd AGM for Monday, 29 September 2025 at 11:30 a.m. in Gujarat, with e-voting open from 26 September (9:00 a.m.) to 28 September (5:00 p.m.). Shareholders will vote on seven items, including adopting FY25 audited financial statements, re-appointing promoter director Mrs. Abha Agrawal (who holds 8.39% stake and retires by rotation), and re-appointing statutory auditors Jaymin Shah & Associates for one year. A special resolution seeks to re-appoint independent director Mr. Arvind Sapkal for a second five-year term (October 2025 to September 2030), and another to appoint M/s Meenu Maheshwari & Associates as secretarial auditor for five years (FY26–FY30). Two ordinary resolutions seek shareholder approval for ongoing related-party transactions with Ishita Pharmaceuticals and Anvi Lifesciences Private Limited, which may exceed 10% of annual turnover and therefore require member approval under SEBI rules.
Routine governance items, but shareholders should review the related-party transaction resolutions carefully since they involve dealings with entities connected to the promoter family (Managing Director and CFO are partners in Ishita Pharmaceuticals) and could exceed the materiality threshold. Voting outcomes will determine board continuity and the company's ability to continue these transactions.